Anthropic’s Fable Model Back, Policy Mess Persists
Anthropic’s Fable returns to service as the U.S. eases export controls, but a cloudy policy framework keeps investors...
Explore effective strategies for locating undervalued stocks today. Discover opportunities to maximize your investment gains.
18,306 articlesAnthropic’s Fable returns to service as the U.S. eases export controls, but a cloudy policy framework keeps investors...
As July nears, chatter over SpaceX joining the Nasdaq-100 swirls. This article argues that a bigger, more reliable ca...
A single date can redefine a stock's trajectory. For Netflix, July 16 may hold the key to whether NFLX resumes its cl...
Two platform leaders redefine how we shop and travel. This guide breaks down which stock—DoorDash or Uber Technologie...
As markets rally into mid-2026, analysts spotlight five stock setups where Wall Street sees the most upside, driven b...
CoreWeave has dropped substantially from its 52-week peak, leaving investors debating whether the bounce is coming or...
Meta Platforms has surged 21% this month, reshaping the investing narrative around growth, ads, and AI. This guide br...
Richtech Robotics faced a sharp pullback in early 2026, driven by execution missteps and market concerns. This piece ...
Lucid faces a pivotal year as production scales and capital needs rise. This guide outlines plausible paths for where...
Three dividend ETFs designed for conservative retirees blend income with risk management, offering low fees and high-...
Trump’s tariff threat makes markets pivot, accelerating a rotation from U.S. stocks to international equities. The Va...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...